Skip to main content

Table 2 Primer used to amplify the dopamine receptor, beta-actin and their competitive mutants

From: Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients

    product
Target Primer primer sequence length (bp)
D3R Upstream 5'-ACG-ACA-TGG-CTG-GGC-TAC-G-3' 155
  Downstream 5' -GCC-AAC-AGC-CTG-GCG-CTA-G-3'  
D5R Upstream 5'-GTC-GCC-GAG-GTG-GCC-GGT-TAC-3' 362
  Downstream 5'-GCT-GGA-GTC-AGA-ATT-CTC-TGC-AT-3'  
BA Upstream 5'-CGT-GGG-CCG-CCC-TAG-GCA-CCA-3' 260
  Downstream 5'-TTG-GCC-TTA-GGG-TTC-AGG-GGG-G-3'  
Mutant D3R Upstream 5' -TCA-AGA-GTT-CCC-TAT-CAC-TCT-CAA-GTT- 474
   TCG-TGA-GCT-GAT -TG-3'  
  Down stream 5'-GTC-GCC-GAG-GTG-GCC-GGT-TAC-CAA-GTT-  
   TCG-TGA-GCT-GAT -TG-3'  
Mutant D5R Upstream 5'-GTC-GCC-GAG-GTG-GCC-GGT-TAC-CAA-GTT- 435
   TCG-TGA-GCT-GAT -TG-3'  
  Downstream 5'-GCT-GGA-GTC-AGA-ATT-CTC-TGC-ATA-TTT-  
   GAT-TCT-GGA-CCA-TGG-C-3'  
Mutant βA Upstream 5'-TTG-GCC-TTA-GGG-TTC-AGG-GGG-GAT-TTG- 429
   ATT-CTG-GAC-CAT-GGC-3'  
  Downstream 5'-CGT-GGG-CCG-CCC-TAG-GCA-CCA-CAA-GTT-  
   TCG-TGA-GCT -GAT-TG-3'